Detalhe da pesquisa
1.
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Blood
; 134(5): 432-444, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151986
2.
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Blood
; 122(15): 2539-49, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23886836
3.
Recombination activation gene-2-deficient blastocyst complementation analysis reveals an essential role for nuclear factor I-A transcription factor in T-cell activation.
Int Immunol
; 23(6): 385-90, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21602176
4.
ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo.
Exp Hematol
; 43(9): 770-4.e2, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937048